1624 related articles for article (PubMed ID: 26921617)
21. Dynamic microglia alterations associate with hippocampal network impairments: A turning point in amyloid pathology progression.
Pizzirusso G; Preka E; Goikolea J; Aguilar-Ruiz C; Rodriguez-Rodriguez P; Vazquez-Cabrera G; Laterza S; Latorre-Leal M; Eroli F; Blomgren K; Maioli S; Nilsson P; Fragkopoulou A; Fisahn A; Arroyo-García LE
Brain Behav Immun; 2024 Jul; 119():286-300. PubMed ID: 38608739
[TBL] [Abstract][Full Text] [Related]
22. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.
Bosch ME; Dodiya HB; Michalkiewicz J; Lee C; Shaik SM; Weigle IQ; Zhang C; Osborn J; Nambiar A; Patel P; Parhizkar S; Zhang X; Laury ML; Mondal P; Gomm A; Schipma MJ; Mallah D; Butovsky O; Chang EB; Tanzi RE; Gilbert JA; Holtzman DM; Sisodia SS
Mol Neurodegener; 2024 Feb; 19(1):18. PubMed ID: 38365827
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.
Lee J; Kim DE; Griffin P; Sheehan PW; Kim DH; Musiek ES; Yoon SY
Aging Cell; 2020 Feb; 19(2):e13078. PubMed ID: 31800167
[TBL] [Abstract][Full Text] [Related]
24. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
[TBL] [Abstract][Full Text] [Related]
25. Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.
Müller-Schiffmann A; Herring A; Abdel-Hafiz L; Chepkova AN; Schäble S; Wedel D; Horn AH; Sticht H; de Souza Silva MA; Gottmann K; Sergeeva OA; Huston JP; Keyvani K; Korth C
Brain; 2016 Feb; 139(Pt 2):509-25. PubMed ID: 26657517
[TBL] [Abstract][Full Text] [Related]
26. Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia.
Benitez DP; Jiang S; Wood J; Wang R; Hall CM; Peerboom C; Wong N; Stringer KM; Vitanova KS; Smith VC; Joshi D; Saito T; Saido TC; Hardy J; Hanrieder J; De Strooper B; Salih DA; Tripathi T; Edwards FA; Cummings DM
Mol Neurodegener; 2021 Jul; 16(1):47. PubMed ID: 34266459
[TBL] [Abstract][Full Text] [Related]
27. The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease.
Long-Smith CM; Manning S; McClean PL; Coakley MF; O'Halloran DJ; Holscher C; O'Neill C
Neuromolecular Med; 2013 Mar; 15(1):102-14. PubMed ID: 23011726
[TBL] [Abstract][Full Text] [Related]
28. Chronic treatments with a 5-HT
Baranger K; Giannoni P; Girard SD; Girot S; Gaven F; Stephan D; Migliorati M; Khrestchatisky M; Bockaert J; Marchetti-Gauthier E; Rivera S; Claeysen S; Roman FS
Neuropharmacology; 2017 Nov; 126():128-141. PubMed ID: 28844596
[TBL] [Abstract][Full Text] [Related]
29. Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain.
Mazzitelli S; Filipello F; Rasile M; Lauranzano E; Starvaggi-Cucuzza C; Tamborini M; Pozzi D; Barajon I; Giorgino T; Natalello A; Matteoli M
Acta Neuropathol Commun; 2016 Oct; 4(1):110. PubMed ID: 27724899
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice.
Eskandari-Sedighi G; Crichton M; Zia S; Gomez-Cardona E; Cortez LM; Patel ZH; Takahashi-Yamashiro K; St Laurent CD; Sidhu G; Sarkar S; Aghanya V; Sim VL; Tan Q; Julien O; Plemel JR; Macauley MS
Mol Neurodegener; 2024 May; 19(1):42. PubMed ID: 38802940
[TBL] [Abstract][Full Text] [Related]
31. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model.
Spangenberg E; Severson PL; Hohsfield LA; Crapser J; Zhang J; Burton EA; Zhang Y; Spevak W; Lin J; Phan NY; Habets G; Rymar A; Tsang G; Walters J; Nespi M; Singh P; Broome S; Ibrahim P; Zhang C; Bollag G; West BL; Green KN
Nat Commun; 2019 Aug; 10(1):3758. PubMed ID: 31434879
[TBL] [Abstract][Full Text] [Related]
32. Accelerated microglial pathology is associated with Aβ plaques in mouse models of Alzheimer's disease.
Baron R; Babcock AA; Nemirovsky A; Finsen B; Monsonego A
Aging Cell; 2014 Aug; 13(4):584-95. PubMed ID: 24641683
[TBL] [Abstract][Full Text] [Related]
33. The Y-Box Binding Protein 1 Suppresses Alzheimer's Disease Progression in Two Animal Models.
Bobkova NV; Lyabin DN; Medvinskaya NI; Samokhin AN; Nekrasov PV; Nesterova IV; Aleksandrova IY; Tatarnikova OG; Bobylev AG; Vikhlyantsev IM; Kukharsky MS; Ustyugov AA; Polyakov DN; Eliseeva IA; Kretov DA; Guryanov SG; Ovchinnikov LP
PLoS One; 2015; 10(9):e0138867. PubMed ID: 26394155
[TBL] [Abstract][Full Text] [Related]
34. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model.
Zhong L; Xu Y; Zhuo R; Wang T; Wang K; Huang R; Wang D; Gao Y; Zhu Y; Sheng X; Chen K; Wang N; Zhu L; Can D; Marten Y; Shinohara M; Liu CC; Du D; Sun H; Wen L; Xu H; Bu G; Chen XF
Nat Commun; 2019 Mar; 10(1):1365. PubMed ID: 30911003
[TBL] [Abstract][Full Text] [Related]
35. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
Duffy AM; Hölscher C
Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
[TBL] [Abstract][Full Text] [Related]
36. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
[TBL] [Abstract][Full Text] [Related]
37. Chronic neuron- and age-selective down-regulation of TNF receptor expression in triple-transgenic Alzheimer disease mice leads to significant modulation of amyloid- and Tau-related pathologies.
Montgomery SL; Narrow WC; Mastrangelo MA; Olschowka JA; O'Banion MK; Bowers WJ
Am J Pathol; 2013 Jun; 182(6):2285-97. PubMed ID: 23567638
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective role of γ-enolase in microglia in a mouse model of Alzheimer's disease is regulated by cathepsin X.
Hafner A; Glavan G; Obermajer N; Živin M; Schliebs R; Kos J
Aging Cell; 2013 Aug; 12(4):604-14. PubMed ID: 23621429
[TBL] [Abstract][Full Text] [Related]
39. Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain.
Crapser JD; Spangenberg EE; Barahona RA; Arreola MA; Hohsfield LA; Green KN
EBioMedicine; 2020 Aug; 58():102919. PubMed ID: 32745992
[TBL] [Abstract][Full Text] [Related]
40. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
Katsouri L; Georgopoulos S
PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
